Blood Test Analysis Identifies Early-Stage Tumors
|
By LabMedica International staff writers Posted on 04 Apr 2017 |
|
Image: The CancerLocator method focuses on DNA methylation, which is depicted in this image. The two white spheres represent methyl groups bound to two cytosine nucleotide molecules (Photo courtesy of Wikimedia Commons).
The development of a blood test that screens for methylated DNA from tumor cells may herald an era of simpler and more precise cancer diagnostics.
Currently there is no existing cell-free DNA (cfDNA)-based method that is able to simultaneously detect cancer and predict its tissue of origin. To fill this gap investigators at the University of California, Los Angeles have proposed a novel method, CancerLocator, which simultaneously infers the proportion and tissue of origin of circulating DNA in a blood sample using genome-wide DNA methylation data.
CancerLocator identifies specific methylation patterns in circulating cancer DNA from different cancer types and compares the patterns to those in a tumor epigenetics database. Since DNA from tumor cells enters the bloodstream in the earliest stages of cancer, this approach offers a method for early detection of the disease.
In a pre-clinical study CancerLocator and two other programs were used to analyze blood samples from 29 liver cancer patients, 12 lung cancer patients, and five breast cancer patients. CancerLocator correctly identified 25 of 29 liver cancer patients and five of 12 lung cancer patients with early stage cancers. Overall CancerLocator had an overall error rate of 0.265 compared to the other two programs, which had rates of 0.646 and 0.604.
Senior author Dr. Xianghong Jasmine Zhou said, "We built a database of epigenetic markers, specifically methylation patterns, which are common across many types of cancer and also specific to cancers originating from specific tissue, such as the lung or liver. We also compiled the same molecular footprint for non-cancerous samples so we had a baseline footprint to compare the cancer samples against. These markers can be used to deconvolute the DNA found freely in the blood into tumor DNA and non-tumor DNA. Non-invasive diagnosis of cancer is important, as it allows the early diagnosis of cancer, and the earlier the cancer is caught the higher chance a patient has of beating the disease. We have developed a computer-driven test that can detect cancer, and also identify the type of cancer, from a single blood sample. The technology is in its infancy and requires further validation, but the potential benefits to patients are huge."
The CancerLocator program was described in the March 24, 2017, online edition of the journal Genome Biology.
Currently there is no existing cell-free DNA (cfDNA)-based method that is able to simultaneously detect cancer and predict its tissue of origin. To fill this gap investigators at the University of California, Los Angeles have proposed a novel method, CancerLocator, which simultaneously infers the proportion and tissue of origin of circulating DNA in a blood sample using genome-wide DNA methylation data.
CancerLocator identifies specific methylation patterns in circulating cancer DNA from different cancer types and compares the patterns to those in a tumor epigenetics database. Since DNA from tumor cells enters the bloodstream in the earliest stages of cancer, this approach offers a method for early detection of the disease.
In a pre-clinical study CancerLocator and two other programs were used to analyze blood samples from 29 liver cancer patients, 12 lung cancer patients, and five breast cancer patients. CancerLocator correctly identified 25 of 29 liver cancer patients and five of 12 lung cancer patients with early stage cancers. Overall CancerLocator had an overall error rate of 0.265 compared to the other two programs, which had rates of 0.646 and 0.604.
Senior author Dr. Xianghong Jasmine Zhou said, "We built a database of epigenetic markers, specifically methylation patterns, which are common across many types of cancer and also specific to cancers originating from specific tissue, such as the lung or liver. We also compiled the same molecular footprint for non-cancerous samples so we had a baseline footprint to compare the cancer samples against. These markers can be used to deconvolute the DNA found freely in the blood into tumor DNA and non-tumor DNA. Non-invasive diagnosis of cancer is important, as it allows the early diagnosis of cancer, and the earlier the cancer is caught the higher chance a patient has of beating the disease. We have developed a computer-driven test that can detect cancer, and also identify the type of cancer, from a single blood sample. The technology is in its infancy and requires further validation, but the potential benefits to patients are huge."
The CancerLocator program was described in the March 24, 2017, online edition of the journal Genome Biology.
New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Progesterone Serum Assay
Progesterone ELISA Kit
Latest Molecular Diagnostics News
- Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
- Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
- Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
- Integrating Multiple Protein Markers Predicts Health Outcomes in Chronic Kidney Disease Patients
- Rapid Finger Prick Blood Test to Detect Active Syphilis at Point of Care
- Urine Tests Could Reveal Early Signs of Cancer and Other Diseases
- AI-Powered Smart PCR System to Revolutionize Clinical Diagnostics
- Simple Blood Test Identifies Women in Labor at Risk for Preeclampsia
- Point-Of-Care Paper-Based Test Could Diagnose Cancer at Bedside
- Sepsis Test Demonstrates Clinical Utility in Critically Ill Heterogeneous Patient Populations
- Multi-Cancer Early Detection Test Measures Host Response to Tumor Development
- MicroRNA-Based Test Identifies 12 Cancers Simultaneously Across Any Stage
- New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease
- First-Ever Blood Test Diagnoses Maternal Autoantibody Related Autism
- Precision Medicine Blood Test Predicts Heart Disease Before It Occurs
- Blood-Based PCR Test Guides Alzheimer's Therapy
Channels
Clinical Chemistry
view channel.jpg "Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)")
POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more
Screening Tool Detects Multiple Health Conditions from Single Blood Drop
Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more
Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more
Hematology
view channel
Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more
Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more
Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more
Immunology
view channel
Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients
Immunotherapy aims to enhance the body’s immune response to target cancer cells, but not all patients experience a positive reaction to such treatments. Identifying which patients will benefit from immunotherapy... Read more
Biomarker Could Predict Immunotherapy Response in Liver Cancer
Until recently, patients diagnosed with hepatocellular carcinoma had limited treatment options, with existing therapies extending life by only a few months. Immunotherapy has emerged as a new alternative... Read more
Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma
Multiple myeloma is a blood cancer that primarily affects individuals over the age of sixty, and its occurrence rises as the population ages. In this disease, the bone marrow—the spongy tissue inside bones... Read more
Microbiology
view channel
High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more_1.jpg "Image: Researchers have developed a method to quickly identify the most appropriate treatments for bacterial infections (Photo courtesy of Shutterstock)")
Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
For patients with bacterial infections, timely treatment with the appropriate antibiotics significantly improves their chances of recovery. Current methods for identifying which antibiotics will be effective... Read more
Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the... Read more
Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR
Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read morePathology
view channel
New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers
Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more
Faster Measurement of Vibrational Fingerprint of Molecules to Advance Biomedical Diagnostics
Identifying different types of molecules and cells is a vital process in both basic and applied science. Raman spectroscopy serves as a widely utilized measurement technique for this purpose.... Read more
Technology
view channel
New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC
Exposure to lead can negatively affect health in multiple ways, leading to damage in the brain and central nervous system, delays in development and growth, learning and behavioral issues, problems with... Read more
Noninvasive Test Detects Malaria Without Blood Sample
Malaria remains a significant global health issue, with approximately 250 million cases and over 600,000 deaths reported annually. Nearly half of the world's population is at risk for malaria infection,... Read more
Industry
view channel
Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests
Acute kidney injury (AKI) is a sudden episode of kidney failure or damage that can occur within a few hours or days. This condition leads to the accumulation of waste products in the blood and disrupts... Read more_1.jpg "Image: CACLP 2025 will return on 21-24 March 2025 to attract professionals across the IVD industry (Photo courtesy of CACLP)")
CACLP 2025 New Date and Venue Announced
The 22nd China International In Vitro Diagnostic Expo, organized by the China Association of Clinical Laboratory Practice Expo (CACLP, Shanghai, China), is set to take place from March 21 to 24, 2025,... Read more
Roche to Develop New Diagnostic Technologies for Traumatic Brain Injuries
Traumatic brain injuries (TBI) represent a significant global health issue, affecting approximately 69 million people each year. TBI occurs when an external force disrupts normal brain function, with severity... Read more